Colorectal Cancer Treatments and Therapy Innovations
In this interview we discuss the advances in treatment for colorectal cancer, as well as ongoing developments to find new and better therapies to treat this type of cancer. (Source: Cancer Network)
Source: Cancer Network - May 22, 2013 Category: Cancer & Oncology Source Type: news

Bone Metastases
This slide show features images of diffuse osteoblastic bone metastases in a 70-year-old advanced prostate cancer patient, bone metastases in the vertebral column of a kidney cancer patient, and more. (Source: Cancer Network)
Source: Cancer Network - May 21, 2013 Category: Cancer & Oncology Source Type: news

Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
Findings suggesting that obesity substantially impairs the ability of L-asparaginase to kill leukemia cells were reported last month by investigators from The Saban Research Institute, Children’s Hospital Los Angeles. (Source: Cancer Network)
Source: Cancer Network - May 20, 2013 Category: Cancer & Oncology Source Type: news

Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
A large study shows that middle-age men engaged in lots of cardiovascular exercise have a reduced risk of developing and dying from lung and colorectal cancer. (Source: Cancer Network)
Source: Cancer Network - May 20, 2013 Category: Cancer & Oncology Source Type: news

Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Palliative radiotherapy is an effective means of alleviating pain and improving overall quality of life in elderly patients with bone metastases, according to a new study. (Source: Cancer Network)
Source: Cancer Network - May 20, 2013 Category: Cancer & Oncology Source Type: news

New AUA Guidelines for Prostate Cancer Screening
The American Urological Association (AUA) released a new clinical guideline detailing recommendations for the use of prostate cancer screening in average-risk men based upon evidence from a systematic literature review. The guideline, which was announced during the 2013 AUA Annual Meeting, recommends that men aged 55 to 69 years who are considering undergoing prostate cancer screening should talk with their physicians about the benefits and risks of screening. (Source: Cancer Network)
Source: Cancer Network - May 19, 2013 Category: Cancer & Oncology Source Type: news

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis? (Source: Cancer Network)
Source: Cancer Network - May 17, 2013 Category: Cancer & Oncology Source Type: news

Genomics Studies Identify Testicular Cancer Risk Variants
Two genome-wide studies have identified a total of 12 new genetic loci associated with a higher risk of testicular cancer. The risk-associated genetic variations could help clinicians single out higher-risk men for screening and early detection. (Source: Cancer Network)
Source: Cancer Network - May 17, 2013 Category: Cancer & Oncology Source Type: news

50 Shades of Pink—And Why It Helps to Know the Difference
Buy toxic chemicals and support breast cancer research! Not lying—just saw an ad on TV for weed killer and it had a pink ribbon logo on its packaging indicating, “A portion of every sale goes to support breast cancer research and awareness.” We have plenty of weed killer and a perfect lawn at our house, so I am no critic of the product. But have you noticed the pink ribbon logo on virtually every conceivable item or service? (Source: Cancer Network)
Source: Cancer Network - May 17, 2013 Category: Cancer & Oncology Source Type: news

Statin Use Improved Survival Post-Nephrectomy for RCC
The use of statins was independently associated with improvements in overall survival and disease-specific survival among a group of patients who had undergone partial or radical nephrectomy for renal cell carcinoma. (Source: Cancer Network)
Source: Cancer Network - May 16, 2013 Category: Cancer & Oncology Source Type: news

Radium-223 Gets Early FDA Nod for Bone Mets in Castration-Resistant Prostate Cancer
Radium-223 dichloride (Xofigo) received FDA approval for the treatment of symptomatic metastatic castration-resistant prostate cancer that has metastasized to the bone but no other organs. (Source: Cancer Network)
Source: Cancer Network - May 16, 2013 Category: Cancer & Oncology Source Type: news

FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
The FDA approved a label expansion for erlotinib (Tarceva), along with the cobas EGFR mutation diagnostic test, to include patients untreated metastatic NSCLC patients whose tumors have either a deletion in exon 19 or exon 21 (L858R) substitution mutations in the EGFR gene. (Source: Cancer Network)
Source: Cancer Network - May 16, 2013 Category: Cancer & Oncology Source Type: news

Introducing Three New Features
No doubt you’ve already been struck by how different the cover of this issue of ONCOLOGY looks. We hope you like our new look! More importantly, we hope you’ll like the new features we've added. (Source: Cancer Network)
Source: Cancer Network - May 15, 2013 Category: Cancer & Oncology Source Type: news

How the Sequester Cuts Are Harming Oncology
Now is a critical moment for all involved in caring for cancer patients to engage in this national policy debate; numerous cancer advocacy organizations have already joined the effort to oppose the sequester cuts to oncology drugs. (Source: Cancer Network)
Source: Cancer Network - May 15, 2013 Category: Cancer & Oncology Source Type: news

Secondary Hormone Therapy for Castration-Resistant Prostate Cancer
The majority of patients with systemic prostate cancer treated with androgen deprivation therapy (ADT) will develop castration-resistant prostate cancer (CRPC). (Source: Cancer Network)
Source: Cancer Network - May 15, 2013 Category: Cancer & Oncology Source Type: news